ARTA
GENE

A.R.T. Advisors’s Genetic Technologies Ltd. GENE Stock Holding History

A.R.T. Advisors’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-131
Closed -$7K – 1709
2014
Q3 		$7K Hold
131
– – ﹤0.01% 1268
2014
Q2 		$14K Sell
131
-18
-12% -$2.15K ﹤0.01% 1272
2014
Q1 		$20K Buy
+149
New +$23.8K ﹤0.01% 1291

Other funds holding GENE

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $150M AUM 32.35% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
APU
Alpine Partners USVI St. Thomas, U.S. Virgin Islands $30.1M AUM

A.R.T. Advisors's GENE Position: Q4 2014 in Review

A.R.T. Advisors sold out of Genetic Technologies Ltd. (GENE) in Q4 2014, closing a stake of 131 shares — an estimated $7K sold.

A.R.T. Advisors first reported a position in GENE in Q1 2014 and held it in 3 quarters. The position peaked at $20K in Q1 2014. 5 funds tracked by Wall St. Rank hold GENE as of Q4 2014.

  • A.R.T. Advisors reported no remaining Genetic Technologies Ltd. position as of Q4 2014 after selling out during the quarter.
  • A.R.T. Advisors sold 131 Genetic Technologies Ltd. shares in Q4 2014, an estimated $7K.
  • A.R.T. Advisors first reported a position in Genetic Technologies Ltd. in Q1 2014 and held it in 3 quarters.
  • A.R.T. Advisors's Genetic Technologies Ltd. position peaked at $20K in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q4 2014.

Based on A.R.T. Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.